We are live on ! Find out more
MGRX icon

Mangoceuticals
MGRX

18 hedge funds and large institutions have $298K invested in Mangoceuticals in 2026 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 1

25% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 4

0% more funds holding

Funds holding: 18 → 18 (0)

84% less capital invested

Capital invested by funds: $1.88M → $298K (-$1.58M)

Holders
18
Holders Change
–
Holders Change %
0%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
5
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$41.3K
2
VF
Virtu Financial
New York
+$13.2K
3
Jane Street
Jane Street
New York
+$12.1K
4
SG
StoneX Group
New York
+$7.68K
5
XT
XTX Topco
Cayman Islands
+$6.3K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$1.14M
2
UBS Group
UBS Group
Switzerland
-$34.2K
3
TRCT
Tower Research Capital (TRC)
New York
-$104
4
Bank of America
Bank of America
North Carolina
-$79
5
Citigroup
Citigroup
New York
-$1
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
1
Geode Capital Management
Massachusetts
$70K +$41.3K +86,160 +80%
IC
2
Ikarian Capital
Texas
$49.7K – – –
VCM
3
Vanguard Capital Management
Pennsylvania
$44.3K +$58.9K +123,041 New
Jane Street
4
Jane Street
New York
$26.2K +$12.1K +25,243 +53%
VF
5
Virtu Financial
New York
$22K +$13.2K +27,566 +82%
VFT
6
Vanguard Fiduciary Trust
Pennsylvania
$20.6K +$27.4K +57,163 New
BFM
7
Boothbay Fund Management
New York
$13.8K – – –
Northern Trust
8
Northern Trust
Illinois
$13.5K – – –
ACA
9
Ackerman Capital Advisors
Texas
$12.4K – – –
SG
10
StoneX Group
New York
$5.78K +$7.68K +16,039 New
XT
11
XTX Topco
Cayman Islands
$4.73K +$6.3K +13,142 New
SS
12
Sunbelt Securities
Texas
$4.32K – – –
Goldman Sachs
13
Goldman Sachs
New York
$4.23K +$5.63K +11,757 New
CAG
14
Csenge Advisory Group
Florida
$3.6K – – –
Osaic Holdings
15
Osaic Holdings
Arizona
$1.18K +$192 +400 +14%
FFO
16
Fortitude Family Office
Arizona
$484 +$462 +965 +255%
Morgan Stanley
17
Morgan Stanley
New York
$360 – – –
TRCT
18
Tower Research Capital (TRC)
New York
$283 -$104 -217 -22%
AC
19
Armistice Capital
New York
– -$1.14M -1,536,000 Closed
UBS Group
20
UBS Group
Switzerland
– -$34.2K -46,167 Closed
Bank of America
21
Bank of America
North Carolina
– -$79 -107 Closed
Citigroup
22
Citigroup
New York
– -$1 -1 Closed

MGRX Hedge Fund Activity: Q1 2026 in Review

18 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in Mangoceuticals (MGRX) for Q1 2026, worth a combined $298K — down 84% from $1.88M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new MGRX positions and 4 closed out — a net gain of 1 holder — while 5 added to existing stakes and 1 trimmed.

The largest buyer was Geode Capital Management, adding an estimated $41.3K. The largest seller was Armistice Capital, exiting entirely with an estimated $1.14M sold.

  • 18 institutional investors held Mangoceuticals (MGRX) as of Q1 2026, unchanged from Q4 2025.
  • Funds reported $298K of Mangoceuticals stock for Q1 2026, down 84% quarter-over-quarter.
  • 5 funds opened new Mangoceuticals positions in Q1 2026 and 4 closed out, a net change of +1 holder.
  • The largest Mangoceuticals buyer in Q1 2026 was Geode Capital Management, an estimated $41.3K added.
  • The largest Mangoceuticals seller in Q1 2026 was Armistice Capital, an estimated $1.14M sold.

Based on aggregated 13F filings for Q1 2026.